Bovie Medical Corp (BVX) 3.64 $BVX
Bovie Medical Corporation Announces Fourth Quarter and Full Year 2014 Earnings Call
Business Wire - Mon Feb 09, 12:31PM CST
Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2014 on Friday February 27, 2015 before market open.
BVX: 3.64 (+0.14)
Bovie Medical Provides Update on Recent Developments for J-Plasma(R)
Business Wire - Mon Jan 12, 3:01PM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today provided an update on recent developments for J-Plasma(R).
BVX: 3.64 (+0.14)
Bovie Medical Corporation Further Expands Its Direct Sales Force
Business Wire - Wed Dec 17, 7:30AM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has added two Senior Surgical Device Specialists to its direct sales force. They will be responsible for the J-Plasma(R) roll-out and growth in their assigned territories.
BVX: 3.64 (+0.14)
Bovie Medical Receives FDA 510(k) Approval for Bovie Ultimate(TM) Generator
Business Wire - Tue Dec 16, 8:31AM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has received FDA 510(k) approval for the Bovie Ultimate(TM) generator.
BVX: 3.64 (+0.14)
China Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin and ConMed
M2 - Thu Dec 11, 3:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/c8hrbf/china_surgical) has announced the addition of the "China Surgical Generators Market Outlook to 2020" report to their offering. Our new report, "China Surgical Generators Market Outlook to 2020", provides key market data on the China Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Surgical Generators Market, China 4 Overview of Key Companies in China, Surgical Generators Market 5 Appendix Companies Mentioned: - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - Bovie Medical Corporation - KLS Martin GmbH & Co. KG - Medtronic, Inc. - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/c8...a_surgical
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Asia-Pacific Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin GmbH and ConMed Corporation.
M2 - Wed Dec 10, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/98t4l5/asiapacific) has announced the addition of the "Asia-Pacific Surgical Generators Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Generators Market, Asia-Pacific 4 Surgical Generators Market, Australia 5 Surgical Generators Market, China 6 Surgical Generators Market, India 7 Surgical Generators Market, Japan 8 Surgical Generators Market, South Korea 9 Overview of Key Companies in Asia-Pacific Surgical Generators Market 10 Appendix Companies Mentioned: - Covidien plc - Olympus Corporation - ConMed Corporation - ERBE Elektromedizin GmbH - Bovie Medical Corporation - B. Braun Melsungen AG - KLS Martin GmbH & Co. KG - Medtronic, Inc. For more information visit http://www.researchandmarkets.com/research/98...siapacific
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Bovie Medical to Present at LD Micro Conference on December 3, 2014
Business Wire - Wed Nov 19, 3:06PM CST
Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced today that Robert L. Gershon, the Company's Chief Executive Officer, will be presenting at the LD Micro Conference on Wednesday, December 3, 2014 at 9 a.m. Pacific Time at the Luxe Sunset Boulevard Hotel in Los Angeles. A live webcast of the presentation will be available on the Bovie Medical Investor Relations website at http://www.boviemedical.com/financials.asp. In addition to presenting information on the Company, management will be available for one-on-one meetings.
BVX: 3.64 (+0.14)
Bovie Medical's (BVX) CEO Rob Gershon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
BVX: 3.64 (+0.14)
First Choice Healthcare Appoints Gary Pickett, CPA as New Chief Financial Officer
Marketwired - Fri Nov 07, 7:30AM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"
, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced the appointment of Gary D. Pickett, CPA as the Company's new Chief Financial Officer, Secretary and Treasurer, replacing Donald A. Bittar who has chosen to formally retire. Bittar will, however, continue to serve as a valued member of the Company's Board of Directors.
BVX: 3.64 (+0.14), CAT: 85.13 (+1.60), PGN: 2.88 (-0.07)
Bovie Medical EPS of -$0.04
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:45PM CST
BVX: 3.64 (+0.14)
Bovie Medical Corporation Reports Third Quarter 2014 Results
Business Wire - Thu Nov 06, 3:06PM CST
--Total sales increased 17% year-over-year to $6.8 million
BVX: 3.64 (+0.14)
Bovie Medical Corporation Continues to Expand Its Direct Sales Force
Business Wire - Thu Nov 06, 3:05PM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has added four Senior Surgical Device Specialists and one Associate Surgical Device Specialist to its direct sales force. They will be responsible for the J-Plasma(R) rollout and growth in their assigned territories.
BVX: 3.64 (+0.14)
Bovie Medical Corporation Appoints Shawn D. Roman as Director of Research & Development
Business Wire - Mon Nov 03, 3:30PM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has appointed Shawn D. Roman as Director of Research & Development, effective October 27. In this newly-created position, Mr. Roman will be responsible for the further development and execution of the Company's product portfolio from research through product launch.
BVX: 3.64 (+0.14)
Bovie Med reports on November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:31PM CDT
BVX: 3.64 (+0.14)
Bovie Medical Corporation's Third Quarter 2014 Earnings Conference Call To Be Held on Thursday, November 6, 2014
Business Wire - Thu Oct 16, 3:06PM CDT
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it will issue its financial results for the third quarter ended September 30, 2014 following the close of market on Thursday, November 6, 2014.
BVX: 3.64 (+0.14)
United States Surgical Generators Market Outlook to 2020
M2 - Wed Oct 15, 4:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8nhmrq/united_states) has announced the addition of the "United States Surgical Generators Market Outlook to 2020" report to their offering. "United States Surgical Generators Market Outlook to 2020", provides key market data on the United States Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Scope - Market size data for Surgical Generators market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Generators market. - Global corporate-level profiles of key companies operating within the Surgical Generators market. Companies Mentioned - Covidien plc - Olympus Corporation - ConMed Corporation - Bovie Medical Corporation - ERBE Elektromedizin GmbH - Medtronic, Inc. - MegaDyne Medical Products, Inc. - B. Braun Melsungen AG - AngioDynamics, Inc. - KLS Martin GmbH & Co. KG For more information visit http://www.researchandmarkets.com/research/8n...ted_states
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Global Electrosurgical Devices Market 2014-2018: Leading Vendors are Bovie Medical, Conmed, Covidien & ERBE Elektromedizin
M2 - Wed Oct 01, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4gb49v/global) has announced the addition of the "Global Electrosurgical Devices Market 2014-2018" report to their offering. The Global Electrosurgical Devices market to grow at a CAGR of 5.97% over the period 2013-2018 Electrosurgical devices are used in electrosurgery of tissues. The electrosurgical devices use high-frequency electric current to cut/remove, coagulate, and control bleeding. They are commonly used in many applications by the surgeons. During the process, heat is generated by the electrosurgical device, which is proportional to the resistance and diameter of the tissue. The two most commonly used electrosurgical modalities are monopolar and bipolar. In a monopolar electrosurgical device, the current flows from an output connection on the power unit to the active electrode, whereas in a bipolar electrosurgical device, the current is delivered via a forceps-shaped device in which one of the forceps tines serves as the active electrode. These devices are used in gynecology, dermatology, cardiac, orthopedic, urology, and general surgical procedures. The Global Electrosurgical Devices market is expected to grow because of an increase in minimally invasive surgeries. These surgeries offer advantages such as fast recovery, less risk of post-surgery infection, less pain, and a reduction in the formation of post-surgery scars. According to the report, one of the major growth factors driving this market is the rapidly increasing elderly population in developed and developing countries. Further, the report states that one of the major challenges in the market is the risk involved in the procedures. Risks involved in electrofulguration, electrocoagulation, and electrodessication procedures hamper the growth of the Global Electrosurgical Devices market. To calculate the market size, the report considers the revenue generated from the following electrosurgical devices: - Electrosurgical Generator System - Electrosurgical Instruments and Accessories - Argon and Smoke Management Systems Key Vendors - Bovie Medical - Conmed - Covidien - ERBE Elektromedizin For more information visit http://www.researchandmarkets.com/research/4gb49v/global
BVX: 3.64 (+0.14)
J-Plasma(R) Recognized as an Innovation of the Year by The Society of Laparoendoscopic Surgeons
Business Wire - Wed Sep 03, 6:30AM CDT
Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced that J-Plasma(R) has been recognized as an Innovation of the Year by The Society of Laparoendoscopic Surgeons (SLS).
BVX: 3.64 (+0.14)
Bovie Medical Announces Two New Senior Additions to its Direct Sales Force
Business Wire - Wed Aug 27, 8:00AM CDT
Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced that it has added two experienced sales executives to its direct sales force.
BVX: 3.64 (+0.14)
EU5 Surgical Generators Market Outlook to 2020
M2 - Fri Aug 15, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/97342b/eu5_surgical) has announced the addition of the "EU5 Surgical Generators Market Outlook to 2020" report to their offering. "EU5 Surgical Generators Market Outlook to 2020", provides key market data on the EU5 Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. Scope - Market size data for Surgical Generators market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Generators market. - Global corporate-level profiles of key companies operating within the Surgical Generators market. - Key players covered include Covidien, ERBE Elektromedizin GmbH and ConMed Corporation. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Surgical Generators Market, EU5 4 Surgical Generators Market, France 5 Surgical Generators Market, Germany 6 Surgical Generators Market, Italy 7 Surgical Generators Market, Spain 8 Surgical Generators Market, United Kingdom 9 Overview of Key Companies in EU5 Surgical Generators Market 10 Appendix Companies Mentioned - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - Medtronic, Inc. - KLS Martin GmbH & Co. KG - B. Braun Melsungen AG - Bovie Medical Corporation - MegaDyne Medical Products, Inc. - Lamidey Noury Medical For more information visit http://www.researchandmarkets.com/research/97...5_surgical
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Bovie Medical Corporation Announces Fourth Quarter and Full Year 2014 Earnings Call
Business Wire - Mon Feb 09, 12:31PM CST
Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2014 on Friday February 27, 2015 before market open.
BVX: 3.64 (+0.14)
Bovie Medical Provides Update on Recent Developments for J-Plasma(R)
Business Wire - Mon Jan 12, 3:01PM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today provided an update on recent developments for J-Plasma(R).
BVX: 3.64 (+0.14)
Bovie Medical Corporation Further Expands Its Direct Sales Force
Business Wire - Wed Dec 17, 7:30AM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has added two Senior Surgical Device Specialists to its direct sales force. They will be responsible for the J-Plasma(R) roll-out and growth in their assigned territories.
BVX: 3.64 (+0.14)
Bovie Medical Receives FDA 510(k) Approval for Bovie Ultimate(TM) Generator
Business Wire - Tue Dec 16, 8:31AM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has received FDA 510(k) approval for the Bovie Ultimate(TM) generator.
BVX: 3.64 (+0.14)
China Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin and ConMed
M2 - Thu Dec 11, 3:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/c8hrbf/china_surgical) has announced the addition of the "China Surgical Generators Market Outlook to 2020" report to their offering. Our new report, "China Surgical Generators Market Outlook to 2020", provides key market data on the China Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Surgical Generators Market, China 4 Overview of Key Companies in China, Surgical Generators Market 5 Appendix Companies Mentioned: - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - Bovie Medical Corporation - KLS Martin GmbH & Co. KG - Medtronic, Inc. - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/c8...a_surgical
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Asia-Pacific Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin GmbH and ConMed Corporation.
M2 - Wed Dec 10, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/98t4l5/asiapacific) has announced the addition of the "Asia-Pacific Surgical Generators Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Generators Market, Asia-Pacific 4 Surgical Generators Market, Australia 5 Surgical Generators Market, China 6 Surgical Generators Market, India 7 Surgical Generators Market, Japan 8 Surgical Generators Market, South Korea 9 Overview of Key Companies in Asia-Pacific Surgical Generators Market 10 Appendix Companies Mentioned: - Covidien plc - Olympus Corporation - ConMed Corporation - ERBE Elektromedizin GmbH - Bovie Medical Corporation - B. Braun Melsungen AG - KLS Martin GmbH & Co. KG - Medtronic, Inc. For more information visit http://www.researchandmarkets.com/research/98...siapacific
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Bovie Medical to Present at LD Micro Conference on December 3, 2014
Business Wire - Wed Nov 19, 3:06PM CST
Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced today that Robert L. Gershon, the Company's Chief Executive Officer, will be presenting at the LD Micro Conference on Wednesday, December 3, 2014 at 9 a.m. Pacific Time at the Luxe Sunset Boulevard Hotel in Los Angeles. A live webcast of the presentation will be available on the Bovie Medical Investor Relations website at http://www.boviemedical.com/financials.asp. In addition to presenting information on the Company, management will be available for one-on-one meetings.
BVX: 3.64 (+0.14)
Bovie Medical's (BVX) CEO Rob Gershon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
BVX: 3.64 (+0.14)
First Choice Healthcare Appoints Gary Pickett, CPA as New Chief Financial Officer
Marketwired - Fri Nov 07, 7:30AM CST
First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS" or "First Choice"
, a diversified holding company focused on delivering clinically superior, patient-centric, multi-specialty care through state-of-the-art medical centers of excellence, today announced the appointment of Gary D. Pickett, CPA as the Company's new Chief Financial Officer, Secretary and Treasurer, replacing Donald A. Bittar who has chosen to formally retire. Bittar will, however, continue to serve as a valued member of the Company's Board of Directors. BVX: 3.64 (+0.14), CAT: 85.13 (+1.60), PGN: 2.88 (-0.07)
Bovie Medical EPS of -$0.04
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:45PM CST
BVX: 3.64 (+0.14)
Bovie Medical Corporation Reports Third Quarter 2014 Results
Business Wire - Thu Nov 06, 3:06PM CST
--Total sales increased 17% year-over-year to $6.8 million
BVX: 3.64 (+0.14)
Bovie Medical Corporation Continues to Expand Its Direct Sales Force
Business Wire - Thu Nov 06, 3:05PM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has added four Senior Surgical Device Specialists and one Associate Surgical Device Specialist to its direct sales force. They will be responsible for the J-Plasma(R) rollout and growth in their assigned territories.
BVX: 3.64 (+0.14)
Bovie Medical Corporation Appoints Shawn D. Roman as Director of Research & Development
Business Wire - Mon Nov 03, 3:30PM CST
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it has appointed Shawn D. Roman as Director of Research & Development, effective October 27. In this newly-created position, Mr. Roman will be responsible for the further development and execution of the Company's product portfolio from research through product launch.
BVX: 3.64 (+0.14)
Bovie Med reports on November 6
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:31PM CDT
BVX: 3.64 (+0.14)
Bovie Medical Corporation's Third Quarter 2014 Earnings Conference Call To Be Held on Thursday, November 6, 2014
Business Wire - Thu Oct 16, 3:06PM CDT
Bovie Medical Corporation (NYSE:BVX), a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced that it will issue its financial results for the third quarter ended September 30, 2014 following the close of market on Thursday, November 6, 2014.
BVX: 3.64 (+0.14)
United States Surgical Generators Market Outlook to 2020
M2 - Wed Oct 15, 4:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8nhmrq/united_states) has announced the addition of the "United States Surgical Generators Market Outlook to 2020" report to their offering. "United States Surgical Generators Market Outlook to 2020", provides key market data on the United States Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Scope - Market size data for Surgical Generators market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Generators market. - Global corporate-level profiles of key companies operating within the Surgical Generators market. Companies Mentioned - Covidien plc - Olympus Corporation - ConMed Corporation - Bovie Medical Corporation - ERBE Elektromedizin GmbH - Medtronic, Inc. - MegaDyne Medical Products, Inc. - B. Braun Melsungen AG - AngioDynamics, Inc. - KLS Martin GmbH & Co. KG For more information visit http://www.researchandmarkets.com/research/8n...ted_states
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
Global Electrosurgical Devices Market 2014-2018: Leading Vendors are Bovie Medical, Conmed, Covidien & ERBE Elektromedizin
M2 - Wed Oct 01, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4gb49v/global) has announced the addition of the "Global Electrosurgical Devices Market 2014-2018" report to their offering. The Global Electrosurgical Devices market to grow at a CAGR of 5.97% over the period 2013-2018 Electrosurgical devices are used in electrosurgery of tissues. The electrosurgical devices use high-frequency electric current to cut/remove, coagulate, and control bleeding. They are commonly used in many applications by the surgeons. During the process, heat is generated by the electrosurgical device, which is proportional to the resistance and diameter of the tissue. The two most commonly used electrosurgical modalities are monopolar and bipolar. In a monopolar electrosurgical device, the current flows from an output connection on the power unit to the active electrode, whereas in a bipolar electrosurgical device, the current is delivered via a forceps-shaped device in which one of the forceps tines serves as the active electrode. These devices are used in gynecology, dermatology, cardiac, orthopedic, urology, and general surgical procedures. The Global Electrosurgical Devices market is expected to grow because of an increase in minimally invasive surgeries. These surgeries offer advantages such as fast recovery, less risk of post-surgery infection, less pain, and a reduction in the formation of post-surgery scars. According to the report, one of the major growth factors driving this market is the rapidly increasing elderly population in developed and developing countries. Further, the report states that one of the major challenges in the market is the risk involved in the procedures. Risks involved in electrofulguration, electrocoagulation, and electrodessication procedures hamper the growth of the Global Electrosurgical Devices market. To calculate the market size, the report considers the revenue generated from the following electrosurgical devices: - Electrosurgical Generator System - Electrosurgical Instruments and Accessories - Argon and Smoke Management Systems Key Vendors - Bovie Medical - Conmed - Covidien - ERBE Elektromedizin For more information visit http://www.researchandmarkets.com/research/4gb49v/global
BVX: 3.64 (+0.14)
J-Plasma(R) Recognized as an Innovation of the Year by The Society of Laparoendoscopic Surgeons
Business Wire - Wed Sep 03, 6:30AM CDT
Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced that J-Plasma(R) has been recognized as an Innovation of the Year by The Society of Laparoendoscopic Surgeons (SLS).
BVX: 3.64 (+0.14)
Bovie Medical Announces Two New Senior Additions to its Direct Sales Force
Business Wire - Wed Aug 27, 8:00AM CDT
Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced that it has added two experienced sales executives to its direct sales force.
BVX: 3.64 (+0.14)
EU5 Surgical Generators Market Outlook to 2020
M2 - Fri Aug 15, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/97342b/eu5_surgical) has announced the addition of the "EU5 Surgical Generators Market Outlook to 2020" report to their offering. "EU5 Surgical Generators Market Outlook to 2020", provides key market data on the EU5 Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. Scope - Market size data for Surgical Generators market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Generators market. - Global corporate-level profiles of key companies operating within the Surgical Generators market. - Key players covered include Covidien, ERBE Elektromedizin GmbH and ConMed Corporation. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Surgical Generators Market, EU5 4 Surgical Generators Market, France 5 Surgical Generators Market, Germany 6 Surgical Generators Market, Italy 7 Surgical Generators Market, Spain 8 Surgical Generators Market, United Kingdom 9 Overview of Key Companies in EU5 Surgical Generators Market 10 Appendix Companies Mentioned - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - Medtronic, Inc. - KLS Martin GmbH & Co. KG - B. Braun Melsungen AG - Bovie Medical Corporation - MegaDyne Medical Products, Inc. - Lamidey Noury Medical For more information visit http://www.researchandmarkets.com/research/97...5_surgical
MDT: 75.26 (+0.33), BVX: 3.64 (+0.14)
